Agenus (AGEN) Long-Term Debt Issuances (2013 - 2025)
Agenus (AGEN) posted quarterly Long-Term Debt Issuances of $10.0 million for Q4 2025, down 50.0% year-over-year from $20.0 million in Q4 2024, and up 300.0% quarter-over-quarter from $2.5 million in Q1 2025.
Analysis
Agenus (AGEN) Long-Term Debt Issuances (2013 - 2025) Analysis & Trends
Agenus' Long-Term Debt Issuances history runs 8 years deep, the most recent figure standing at $10.0 million for Q4 2025.
- In Q4 2025, Long-Term Debt Issuances fell 50.0% year-over-year to $10.0 million; the TTM figure through Mar 2026 stood at $10.0 million (down 55.56% YoY), while the FY2025 annual figure was $12.5 million, down 37.5% from the prior year.
- Long-Term Debt Issuances for Q4 2025 stood at $10.0 million, up from $2.5 million in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $20.0 million in Q4 2024, with the low at $230000.0 in Q2 2021.
- The 3-year median for Long-Term Debt Issuances is $2.5 million (2025), against an average of $6.6 million.
- The sharpest annual moves came in 2021 and 2025: Long-Term Debt Issuances plunged 54.0% in 2021, then plunged 50.0% in 2025.
- Agenus' Long-Term Debt Issuances stood at $230000.0 in 2021, then jumped by 8595.65% to $20.0 million in 2024, then slumped by 50.0% to $10.0 million in 2025.
- Business Quant data shows AGEN's Long-Term Debt Issuances at $10.0 million in Q4 2025, $2.5 million in Q1 2025, and $20.0 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Agenus | 342.07 Mn | 342.07 Mn | 34.52 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 10.00 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Jun 30, 2021 | 230,000.00 |
| Mar 31, 2021 | 232,000.00 |
| Jun 30, 2020 | 5.70 Mn |
| Mar 31, 2020 | 500,000.00 |
| Mar 31, 2018 | 161.85 Mn |
| Sep 30, 2015 | 100.00 Mn |
| Mar 31, 2015 | 9.00 Mn |
| Dec 31, 2014 | 833,334.00 |
| Sep 30, 2014 | 4.17 Mn |
| Jun 30, 2014 | -833,334.00 |
| Mar 31, 2014 | -833,333.00 |
| Dec 31, 2013 | 20.00 Mn |
| Jun 30, 2013 | -15.00 Mn |